| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2 | Chou S.-M.; Huang T.-H.; Chen H.-C.; TSAI-KUN LI | Cellular and Molecular Life Sciences | 9 | 8 | |
| 2000 | The camptothecins: Unfolding their anticancer potential: Introduction | Liu L.F.; Desai S.D.; TSAI-KUN LI ; Yong M.A.O.; Sun M.E.I.; Sai-Peng S.I.M. | Annals of the New York Academy of Sciences | |||
| 2012 | Cell type-specific effects of Adenosine 5′-triphosphate and pyrophosphate on the antitumor activity of doxorubicin | Wang J.-S.; Chang Y.-L.; Yu Y.-H.; Chen C.-Y.; Kao M.-C.; TSAI-KUN LI ; Lin W.-W. | Cancer Science | 4 | 4 | |
| 2010 | Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage | Huang T.-H.; Chen H.-C.; Chou S.-M.; Yang Y.-C.; Fan J.-R.; TSAI-KUN LI | Cell Research | 12 | 11 | |
| 2008 | Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses | Fan J.-R.; Peng A.-L.; Chen H.-C.; Lo S.-C.; Huang T.-H.; TSAI-KUN LI | DNA Repair | 41 | 39 | |
| 1996 | Cellular resistance to topoisomerase poisons. | Rubin E.H.; TSAI-KUN LI ; Duann P.; Liu L.F. | Cancer treatment and research | 0 | ||
| 2003 | Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug | TSAI-KUN LI ; Houghton P.J.; Desai S.D.; Daroui P.; Liu A.A.; Hars E.S.; Ruchelman A.L.; LaVoie E.J.; Liu L.F. | Cancer Research | 93 | ||
| 2007 | Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication | Lu C.-C.; Huang H.-T.; Wang J.-T.; Slupphaug G.; TSAI-KUN LI ; Wu M.-C.; Chen Y.-C.; Lee C.-P.; Chen M.-R. | Journal of Virology | 26 | 26 | |
| 2020 | Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases | Lee J.-F.; Chang T.-Y.; Liu Z.-F.; Lee N.-Z.; Yeh Y.-H.; Chen Y.-S.; Chen T.-C.; Chou H.-S.; TSAI-KUN LI ; Lee S.-B.; Lin M.-H. | European Journal of Medicinal Chemistry | 6 | 7 | |
| 2002 | Diaza- and triazachrysenes: Potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435 | Ruchelman A.L.; Singh S.K.; Wu X.; Ray A.; Yang J.-M.; TSAI-KUN LI ; Liu A.; Liu L.F.; LaVoie E.J. | Bioorganic and Medicinal Chemistry Letters | 55 | ||
| 1997 | Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar | Sim S.-P.; Gatto B.; Yu C.; Liu A.A.; TSAI-KUN LI ; Pilch D.S.; LaVoie E.J.; Liu L.F. | Biochemistry | 36 | ||
| 2009 | Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification | You Q.-D.; Li Z.-Y.; Huang C.-H.; Yang Q.; Wang X.-J.; Guo Q.-L.; Chen X.-G.; He X.-G.; TSAI-KUN LI ; Chern J.-W. | Journal of Medicinal Chemistry | 88 | 69 | |
| 2006 | Distribution of gyrase and topoisomerase IV on bacterial nucleoid: Implications for nucleoid organization | Hsu Y.-H.; Chung M.-W.; TSAI-KUN LI | Nucleic Acids Research | 25 | 24 | |
| 2003 | DNA damage-mediated apoptosis induced by selenium compounds | Zhou N.; Xiao H.; TSAI-KUN LI ; Nur-E-Kamal A.; Liu L.F. | Journal of Biological Chemistry | 130 | 123 | |
| 1998 | DNA minor groove binding-directed poisoning of human DNA topoisomerase I by terbenzimidazoles | Xu Z.; TSAI-KUN LI ; Kim J.S.; LaVoie E.J.; Breslauer K.J.; Liu L.F.; Pilch D.S. | Biochemistry | 39 | ||
| 2013 | DNA Topoisomerase II Is Involved in Regulation of Cyst Wall Protein Genes and Differentiation in Giardia lamblia | Lin B.-C.; Su L.-H.; Weng S.-C.; Pan Y.-J.; Chan N.-L.; TSAI-KUN LI ; Wang H.-C.; Sun C.-H. | PLoS Neglected Tropical Diseases | 7 | ||
| 2014 | DNA topoisomerase III alpha regulates P53-mediated tumor suppression | Hsieh M.-Y.; Fan J.-R.; Chang H.-W.; Chen H.-C.; Shen T.-L.; Teng S.-C.; Yeh Y.-H.; TSAI-KUN LI | Clinical Cancer Research | 7 | 6 | |
| 2009 | Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism | Tai C.C.; Chen C.Y.; Lee H.S.; Wang Y.C.; TSAI-KUN LI ; Mersamm H.J.; Ding S.T.; Wang P.H. | Journal of Biological Chemistry | 20 | 20 | |
| 2012 | Docosahexaenoic acid suppresses the expression of FoxO and its target genes | Chen Y.-J.; Chen C.-C.; TSAI-KUN LI ; Wang P.-H.; Liu L.-R.; Chang F.-Y.; Wang Y.-C.; Yu Y.-H.; Lin S.-P.; Mersmann H.J.; Ding S.-T. | Journal of Nutritional Biochemistry | 35 | 33 | |
| 2004 | Drug targeting of HIV-1 RNA·DNA hybrid structures: Thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication | TSAI-KUN LI ; Barbieri C.M.; Lin H.-C.; Rabson A.B.; Yang G.; Fan Y.; Gaffney B.L.; Jones R.A.; Pilch D.S. | Biochemistry | 17 | 16 |
